Protagonist Therapeutics, Inc Annual Operating Income (Loss) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Protagonist Therapeutics, Inc quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2023.
  • Protagonist Therapeutics, Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$41.5M, a 8.16% decline year-over-year.
  • Protagonist Therapeutics, Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $149M.
  • Protagonist Therapeutics, Inc annual Operating Income (Loss) for 2023 was -$93.7M, a 28.7% increase from 2022.
  • Protagonist Therapeutics, Inc annual Operating Income (Loss) for 2022 was -$131M, a 4.39% decline from 2021.
  • Protagonist Therapeutics, Inc annual Operating Income (Loss) for 2021 was -$126M, a 95.1% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$93.7M +$37.7M +28.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 -$131M -$5.53M -4.39% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 -$126M -$61.3M -95.1% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 -$64.5M +$16M +19.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-15
2019 -$80.5M -$38.3M -90.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$42.3M -$4.37M -11.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-10
2017 -$37.9M -$5.23M -16% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-10
2016 -$32.7M -$17.9M -121% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 -$14.8M -$5.48M -58.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 -$9.32M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.